The relationship between testosterone and hair growth is one of the most misunderstood in men’s health. Testosterone does not directly cause hair loss. What matters is how testosterone is metabolized – specifically its conversion to dihydrotestosterone (DHT) – and how genetically sensitive a person’s hair follicles are to DHT signaling.
Understanding this distinction changes how patients and clinicians think about hormone optimization, hair preservation, and treatment decisions.
How Testosterone Affects Hair: The DHT Mechanism
Testosterone is converted to dihydrotestosterone (DHT) by the enzyme 5α-reductase, primarily in the scalp, prostate, and skin. DHT binds androgen receptors in hair follicles with approximately 5 times the affinity of testosterone – making it the primary androgen driver of hair follicle behavior.
In genetically susceptible individuals, DHT causes a process called follicular miniaturization: progressive shrinkage of the hair follicle and its dermal papilla over successive growth cycles. As miniaturization proceeds, the anagen (growth) phase shortens, the telogen (resting) phase lengthens, and terminal hairs gradually convert to fine, unpigmented vellus hairs – then eventually stop producing visible hair entirely.
This is the pathophysiology of androgenetic alopecia (AGA) – the most common form of hair loss, affecting approximately 50% of men by age 50.
The Genetics Matter More Than Testosterone Levels
A critical point: genetic predisposition accounts for approximately 80% of the risk for androgenetic alopecia. DHT and testosterone serve as necessary but insufficient triggers – meaning most men with high DHT will not lose their hair unless they have the genetic sensitivity.
Key genetic factor: variation in the androgen receptor gene (AR) on the X chromosome influences follicle sensitivity to DHT. Patterns of inheritance explain why men often look to their maternal grandfather’s hairline as a predictive signal – though the picture is polygenic and individual variation is substantial.
Practical implication: Not everyone on TRT will experience accelerated hair loss. Those with genetic susceptibility to AGA are at higher risk; those without this predisposition may tolerate TRT without significant hair effects.
Hair Growth and Testosterone: Body Hair vs. Scalp Hair
This relationship varies significantly by body region – a paradox that confuses many patients:
- Scalp hair: DHT shortens the growth cycle and miniaturizes follicles – causing loss in AGA-susceptible individuals
- Body and facial hair: DHT stimulates the growth of coarser, darker body and facial hair (axillary, pubic, beard, chest)
This is because androgen-responsive follicles in different body regions have opposite responses to the same hormonal signal. Scalp follicles in AGA-susceptible individuals are programmed to respond to DHT with regression; follicles in the beard and body are programmed to respond with growth.
TRT predictably increases body and facial hair in most users – regardless of genetic susceptibility to scalp AGA.
Does TRT Cause Hair Loss?
TRT can accelerate androgenetic alopecia in men who are genetically susceptible, but it does not cause hair loss de novo in men without the genetic predisposition. The available evidence indicates:
- A 2025 narrative review of hair loss in athletic testosterone use found that in a prospective cohort study, self-reported alopecia rose from 2% at baseline to 12% by the final week of a high-dose anabolic-androgenic steroid (AAS) cycle (PMC11931090, 2025) – importantly, these were supraphysiological doses, not therapeutic TRT
- At physiological TRT doses, hair loss progression is more modest and varies considerably between individuals
- Men who are already experiencing AGA are most likely to notice acceleration; those with no family history and no current AGA signs are at lower risk
The 2025 review also noted that the anabolic steroids with greatest AGA risk are those with the highest androgen receptor binding affinity and least aromatization – again pointing to DHT-receptor interaction as the key driver, not testosterone itself.
Hair Restoration at Ways2Well
Ways2Well offers non-surgical hair restoration options as part of its comprehensive hair loss management approach.
Who Is at Risk of TRT-Related Hair Loss?
Highest risk:
- Men with a personal history of androgenetic alopecia (hair already thinning)
- Men with strong paternal or maternal family history of pattern hair loss
- Those starting TRT at higher doses or using formulations with greater DHT conversion (transdermal gels tend to elevate DHT more than injectable testosterone)
Lower risk:
- Men without personal or family history of AGA
- Younger men on physiological-range TRT with no baseline hair thinning
Pre-TRT evaluation of hair status and family history allows for proactive planning – including concurrent finasteride use if indicated – before hair loss accelerates.
Frequently Asked Questions
Does testosterone cause hair loss?
Testosterone itself does not directly cause hair loss. DHT – testosterone’s more potent metabolite – causes follicular miniaturization in genetically susceptible individuals. Approximately 80% of androgenetic alopecia risk is genetic; testosterone and DHT serve as necessary triggers but don’t cause hair loss in men without the genetic predisposition.
How does TRT affect follicles and testosterone’s influence on follicles?
TRT increases both testosterone and DHT levels, which can accelerate androgenetic alopecia in men who are genetically susceptible. The degree of risk depends on 5α-reductase activity, genetic androgen receptor sensitivity, and the TRT formulation used. Physiological-range TRT carries less risk than supraphysiological anabolic steroid use.
Can you do TRT without losing hair?
Many men do TRT without significant hair loss – especially those without genetic predisposition to AGA. For men who are at risk, combining TRT with finasteride or dutasteride can mitigate DHT-mediated follicular effects while preserving the benefits of testosterone replacement.
What is the best treatment for DHT-related hair loss?
Evidence-based first-line options include finasteride (reduces DHT by 60–70%), minoxidil (topical or low-dose oral), and their combination. PRP scalp injections are a non-surgical regenerative option with growing clinical evidence. Dutasteride is an alternative for finasteride non-responders or for greater DHT suppression.
Does hair loss from testosterone grow back?
Hair loss from follicular miniaturization may partially reverse with early treatment (finasteride, minoxidil), particularly when started before the follicle is permanently lost. Advanced AGA with fully miniaturized follicles is less reversible – which is why early intervention, when hair is thinning but not yet gone, produces the best outcomes.
Key Takeaways
- Testosterone and hair growth are connected primarily through DHT – not testosterone directly
- DHT causes follicular miniaturization → progressive hair thinning → eventual baldness (androgenetic alopecia)
- Genetics account for ~80% of AGA risk – DHT is a trigger, not the sole cause
- Paradox: DHT stimulates body and facial hair but causes scalp hair loss in susceptible individuals
- TRT can accelerate AGA in genetically susceptible men; lower risk at physiological doses; higher risk at supraphysiological doses
- Evidence-based treatments: Finasteride (reduces DHT 60–70%), minoxidil, dutasteride, PRP scalp injections
- Hair growth and testosterone management can coexist – finasteride alongside TRT is a viable strategy for susceptible men
Personalized Hair and Hormone Assessment
Explore non-surgical hair restoration and hormone optimization at Ways2Well.
References
- “Hair loss in athletic testosterone use in males: a narrative review.” PMC11931090 (2025). DOI:
https://doi.org/10.1111/ijd.17567 - “Androgenetic Alopecia: An Update on Pathogenesis and Pharmacological Treatment.” PMC12380480 (2025). https://pubmed.ncbi.nlm.nih.gov/PMC12380480
- “Male Androgenetic Alopecia.”Endotext – NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK/
- “Connection Between Testosterone, DHT and Hair Loss.”ISHRS. https://www.ishrs.org/
- “Serum Levels of Androgen-Associated Hormones Are Correlated with Curative Effect in Androgenic Alopecia in Young Men.” PMC6223099 (2018). https://pubmed.ncbi.nlm.nih.gov/PMC6223099
Author: Ways2Well Editorial Team
Reviewed by: Scientific Advisory Board member